( September 3, 2025, 4:34 PM EDT) -- NEW HAVEN, Conn. — A Connecticut city has sued drug manufacturers and pharmacy benefit managers (PBMs) in a Connecticut federal court, alleging that the companies worked together to artificially raise the price of insulin and other medications to treat diabetes, including glucagon-like peptide-1 receptor agonist (GLP-1) drugs that help control insulin levels....